ムスカリン性アセチルコリン受容体の世界市場レポート 2025年

ムスカリン性アセチルコリン受容体市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で23億7,000万米ドルに成長します。予測期間の成長は、神経薬理学の進歩、心血管疾患患者の増加、眼科治療薬の革新、呼吸器系治療薬の出現、消化器系薬剤パイプラインの拡大などに起因します。予測期間における主な動向としては、眼科疾患での利用、創薬のための戦略的パートナーシップ、組織選択的薬剤の開発、消化器疾患での可能性、個別化治療アプローチの重視などが挙げられます。

神経疾患の有病率の増加は、今後のムスカリン性アセチルコリン受容体（mAChR）市場の成長を牽引すると予想されます。神経疾患には、脳、脊髄、末梢神経を含む神経系に影響を及ぼす病状が含まれます。ムスカリン性アセチルコリン受容体は、認知、運動、報酬などの複雑な行動の制御に重要な役割を果たしており、様々な神経疾患の有望な治療標的となっています。例えば、オーストラリアの政府機関であるAustralian Bureau of Statistics National Health Surveyのデータによると、心臓病と脳卒中の推定有病率は、2001年の4.1％から、2022年には5.2％に増加し、130万人が罹患することが明らかになった。その結果、神経疾患の罹患率の増加がムスカリン性アセチルコリン受容体市場の拡大に拍車をかけています。

緑内障に対する認識と診断の高まりがムスカリン性アセチルコリン受容体市場を大きく押し上げると予想されます。緑内障は視神経を損傷する進行性の眼病であり、眼圧の上昇とそれを調節するムスカリン性アセチルコリン受容体の役割を関連付けることが多いです。2022年10月のBrightFocus Foundationによると、40歳以上の米国人緑内障患者300万人のうち約270万人が開放隅角緑内障を患っており、このタイプが最も多いです。世界的には、緑内障人口は現在の8,000万人から2040年には1億1,100万人以上に達すると予測されています。このように、緑内障とムスカリン受容体との関連性についての理解が深まることが、市場成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ムスカリン性アセチルコリン受容体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のムスカリン性アセチルコリン受容体市場：成長率分析
• 世界のムスカリン性アセチルコリン受容体市場の実績：規模と成長, 2019-2024
• 世界のムスカリン性アセチルコリン受容体市場の予測：規模と成長, 2024-2029, 2034F
• 世界ムスカリン性アセチルコリン受容体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のムスカリン性アセチルコリン受容体市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• M1
• M4
• M5
• その他のタイプ
• 世界のムスカリン性アセチルコリン受容体市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 小売薬局
• オンライン薬局
• 専門センター
• 世界のムスカリン性アセチルコリン受容体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性閉塞性肺疾患
• 注意欠陥多動性障害
• アルツハイマー病
• 記憶障害
• 精神疾患
• その他の用途
• 世界のムスカリン性アセチルコリン受容体市場、M1のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中枢作用拮抗薬
• 中枢作用性アゴニスト
• 末梢作用化合物
• 世界のムスカリン性アセチルコリン受容体市場、M4のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的アゴニスト
• 選択的拮抗薬
• 非選択的薬剤
• 世界のムスカリン性アセチルコリン受容体市場、M5のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アゴニスト
• 敵対者
• その他のモジュレーター
• 世界のムスカリン性アセチルコリン受容体市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• M2受容体
• M3受容体
• 複合受容体製品

第7章 地域別・国別分析

• 世界のムスカリン性アセチルコリン受容体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のムスカリン性アセチルコリン受容体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ムスカリン性アセチルコリン受容体市場：競合情勢
• ムスカリン性アセチルコリン受容体市場：企業プロファイル
  • Heptares Therapeutics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Anavex Life Sciences Corp. Overview, Products and Services, Strategy and Financial Analysis
  • NeuroHealing Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Karuna Pharmaceuticals Inc.
• Anven AlzDx Inc.
• Merck & Co Inc.
• Elsevier BV
• Eurofins Discover X Corporation
• Novus Biologicals LLC
• Eli Lilly and Co.
• Novatein Biosciences Inc.
• Alomone Labs Ltd.
• GlaxoSmithKline plc
• SK Bioscience Co.
• Johnson & Johnson
• Pfizer Inc.
• Novartis AG
• AbbVie Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ムスカリン性アセチルコリン受容体市場2029：新たな機会を提供する国
• ムスカリン性アセチルコリン受容体市場2029：新たな機会を提供するセグメント
• ムスカリン性アセチルコリン受容体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Muscarinic acetylcholine receptors (mAChRs) belong to a class of G protein-coupled receptors (GPCRs) activated by the neurotransmitter acetylcholine. These receptors are widely distributed throughout the body, playing vital roles in numerous physiological processes, particularly within the central and peripheral nervous systems.

The primary types of muscarinic acetylcholine receptors include M1, M4, M5, among others. The M1 subtype is one of the five receptor subtypes involved in mediating the effects of acetylcholine. These receptors are G protein-coupled and participate in various physiological responses to acetylcholine. These receptors are accessible through different distribution channels such as hospitals, clinics, retail pharmacies, online pharmacies, and specialty centers. They find applications in several medical conditions such as chronic obstructive pulmonary disease, attention deficit hyperactivity disorder, Alzheimer's disease, memory impairment, psychiatric disorders, and more.

The muscarinic acetylcholine receptors market research report is one of a series of new reports from The Business Research Company that provides muscarinic acetylcholine receptors market statistics, including muscarinic acetylcholine receptors industry global market size, regional shares, competitors with a muscarinic acetylcholine receptors market share, detailed muscarinic acetylcholine receptors market segments, market trends and opportunities, and any further data you may need to thrive in the muscarinic acetylcholine receptors industry. This muscarinic acetylcholine receptors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The muscarinic acetylcholine receptor market size has grown steadily in recent years. It will grow from$1.82 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to neurological disorders treatment, cardiovascular disorders management, ophthalmic disorders therapies, respiratory conditions treatment, gastrointestinal disorders

The muscarinic acetylcholine receptor market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in neuropharmacology, increasing cardiovascular disease cases, innovations in ophthalmic therapeutics, emerging respiratory therapies, expanding gastrointestinal drug pipeline. Major trends in the forecast period include utilization in ophthalmic conditions, strategic partnerships for drug discovery, development of tissue-selective agents, potential in gastrointestinal disorders, focus on personalized treatment approaches.

The rising prevalence of neurological disorders is anticipated to drive the growth of the muscarinic acetylcholine receptor (mAChR) market in the future. Neurological disorders encompass medical conditions that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Muscarinic acetylcholine receptors play a vital role in regulating complex behaviors such as cognition, locomotion, and reward, making them promising therapeutic targets for various neurological conditions. For example, data from the Australian Bureau of Statistics National Health Survey, a government agency in Australia, revealed that the estimated prevalence of heart disease and stroke increased to 5.2% in 2022, affecting 1.3 million individuals, compared to 4.1% in 2001. Consequently, the growing incidence of neurological disorders is fueling the expansion of the muscarinic acetylcholine receptor market.

The growing awareness and diagnosis of glaucoma are expected to significantly boost the muscarinic acetylcholine receptor market. Glaucoma, a progressive eye disease damaging the optic nerve, often associates increased intraocular pressure with muscarinic acetylcholine receptors' role in regulating it. According to the BrightFocus Foundation in October 2022, about 2.7 million out of three million Americans aged 40 or older with glaucoma suffer from open-angle glaucoma, the most prevalent type. Globally, the glaucoma population is anticipated to reach over 111 million by 2040 from the current 80 million. This increased understanding of glaucoma's link to muscarinic receptors drives the market growth.

The upsurge in research and development initiatives is a pivotal trend shaping the muscarinic acetylcholine receptor market. Companies in this sector are intensifying development activities to fortify their market position. For example, in January 2022, researchers at Merck introduced MK-6884, a carbon-11-labeled molecule detecting the M4 subtype of muscarinic cholinergic receptors. This innovation aids in measuring drug efficacy and neuropathological receptor loss in conditions such as Alzheimer's disease.

Major companies in the muscarinic acetylcholine receptor market are committed to innovating new products, seeking regulatory approval for schizophrenia treatment. Schizophrenia, a severe mental illness impacting thoughts, feelings, and behavior, often causes individuals to seem detached from reality. For instance, in September 2023, Karuna Therapeutics, Inc. submitted a New Drug Application (NDA) for KarXT (xanomeline-trospium) to the FDA for schizophrenia treatment. The company's dedication lies in pioneering innovative treatments for neurological and psychiatric illnesses, striving to address unmet medical needs.

In August 2024, AbbVie, a pharmaceutical company based in the U.S., acquired Cerevel Therapeutics for an undisclosed sum. This acquisition is part of AbbVie's strategy to enhance its neuroscience portfolio, particularly focusing on treatments for conditions such as schizophrenia, Parkinson's disease, and other neurological disorders. Cerevel Therapeutics, also a U.S.-based company, specializes in developing innovative therapies for neurological diseases, including schizophrenia, epilepsy, and Parkinson's disease, and focuses on creating treatments that target muscarinic acetylcholine receptors.

Major companies operating in the muscarinic acetylcholine receptor market include Heptares Therapeutics Ltd., Sumitomo Dainippon Pharma Co. Ltd., Anavex Life Sciences Corp., NeuroHealing Pharmaceuticals Inc., AstraZeneca plc, Karuna Pharmaceuticals Inc., Anven AlzDx Inc., Merck & Co Inc., Elsevier BV, Eurofins Discover X Corporation, Novus Biologicals LLC, Eli Lilly and Co., Novatein Biosciences Inc., Alomone Labs Ltd., GlaxoSmithKline plc, SK Bioscience Co., Johnson & Johnson, Pfizer Inc., Novartis AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Eisai Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sanofi SA, Sun Pharmaceutical Industries Ltd.

North America was the largest region in the muscarinic acetylcholine receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global muscarinic acetylcholine receptor market during the forecast period. The regions covered in the muscarinic acetylcholine receptor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the muscarinic acetylcholine receptor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The muscarinic acetylcholine receptors market consists of sales of extracellular N-terminal segment, transmembrane domains (TM1-TM7), intracellular loops (IL1-IL3), intracellular C-terminal segment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Muscarinic Acetylcholine Receptor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscarinic acetylcholine receptor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for muscarinic acetylcholine receptor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The muscarinic acetylcholine receptor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: M1; M4; M5; Other Types
• 2) By Distribution Channel: Hospitals; Clinics; Retail Pharmacies; Online Pharmacies; Specialty Centers
• 3) By Application: Chronic Obstructive Pulmonary Disease; Attention Deficit Hyperactivity Disorder; Alzheimer's Disease; Memory Impairment; Psychiatric Disorders; Other Applications
• Subsegments:
• 1) By M1 Receptor: Centrally Acting Antagonists; Centrally Acting Agonists; Peripherally Acting Compounds
• 2) By M4 Receptor: Selective Agonists; Selective Antagonists; Non-Selective Agents
• 3) By M5 Receptor: Agonists; Antagonists; Other Modulators
• 4) By Other Types: M2 Receptor; M3 Receptor; Combination Receptor Products
• Companies Mentioned: Heptares Therapeutics Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Anavex Life Sciences Corp.; NeuroHealing Pharmaceuticals Inc.; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Muscarinic Acetylcholine Receptor Market Characteristics

3. Muscarinic Acetylcholine Receptor Market Trends And Strategies

4. Muscarinic Acetylcholine Receptor Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Muscarinic Acetylcholine Receptor Growth Analysis And Strategic Analysis Framework

• 5.1. Global Muscarinic Acetylcholine Receptor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Muscarinic Acetylcholine Receptor Market Growth Rate Analysis
• 5.4. Global Muscarinic Acetylcholine Receptor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Muscarinic Acetylcholine Receptor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Muscarinic Acetylcholine Receptor Total Addressable Market (TAM)

6. Muscarinic Acetylcholine Receptor Market Segmentation

• 6.1. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• M1
• M4
• M5
• Other Types
• 6.2. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Retail Pharmacies
• Online Pharmacies
• Specialty Centers
• 6.3. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease
• Attention Deficit Hyperactivity Disorder
• Alzheimer's Disease
• Memory Impairment
• Psychiatric Disorders
• Other Applications
• 6.4. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrally Acting Antagonists
• Centrally Acting Agonists
• Peripherally Acting Compounds
• 6.5. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M4, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Agonists
• Selective Antagonists
• Non-Selective Agents
• 6.6. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M5, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Agonists
• Antagonists
• Other Modulators
• 6.7. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• M2 Receptor
• M3 Receptor
• Combination Receptor Products

7. Muscarinic Acetylcholine Receptor Market Regional And Country Analysis

• 7.1. Global Muscarinic Acetylcholine Receptor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Muscarinic Acetylcholine Receptor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscarinic Acetylcholine Receptor Market

• 8.1. Asia-Pacific Muscarinic Acetylcholine Receptor Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscarinic Acetylcholine Receptor Market

• 9.1. China Muscarinic Acetylcholine Receptor Market Overview
• 9.2. China Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscarinic Acetylcholine Receptor Market

• 10.1. India Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscarinic Acetylcholine Receptor Market

• 11.1. Japan Muscarinic Acetylcholine Receptor Market Overview
• 11.2. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscarinic Acetylcholine Receptor Market

• 12.1. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscarinic Acetylcholine Receptor Market

• 13.1. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscarinic Acetylcholine Receptor Market

• 14.1. South Korea Muscarinic Acetylcholine Receptor Market Overview
• 14.2. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscarinic Acetylcholine Receptor Market

• 15.1. Western Europe Muscarinic Acetylcholine Receptor Market Overview
• 15.2. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscarinic Acetylcholine Receptor Market

• 16.1. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscarinic Acetylcholine Receptor Market

• 17.1. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscarinic Acetylcholine Receptor Market

• 18.1. France Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscarinic Acetylcholine Receptor Market

• 19.1. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscarinic Acetylcholine Receptor Market

• 20.1. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscarinic Acetylcholine Receptor Market

• 21.1. Eastern Europe Muscarinic Acetylcholine Receptor Market Overview
• 21.2. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscarinic Acetylcholine Receptor Market

• 22.1. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscarinic Acetylcholine Receptor Market

• 23.1. North America Muscarinic Acetylcholine Receptor Market Overview
• 23.2. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscarinic Acetylcholine Receptor Market

• 24.1. USA Muscarinic Acetylcholine Receptor Market Overview
• 24.2. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscarinic Acetylcholine Receptor Market

• 25.1. Canada Muscarinic Acetylcholine Receptor Market Overview
• 25.2. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscarinic Acetylcholine Receptor Market

• 26.1. South America Muscarinic Acetylcholine Receptor Market Overview
• 26.2. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscarinic Acetylcholine Receptor Market

• 27.1. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscarinic Acetylcholine Receptor Market

• 28.1. Middle East Muscarinic Acetylcholine Receptor Market Overview
• 28.2. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscarinic Acetylcholine Receptor Market

• 29.1. Africa Muscarinic Acetylcholine Receptor Market Overview
• 29.2. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscarinic Acetylcholine Receptor Market Competitive Landscape And Company Profiles

• 30.1. Muscarinic Acetylcholine Receptor Market Competitive Landscape
• 30.2. Muscarinic Acetylcholine Receptor Market Company Profiles
  • 30.2.1. Heptares Therapeutics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Anavex Life Sciences Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. NeuroHealing Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Muscarinic Acetylcholine Receptor Market Other Major And Innovative Companies

• 31.1. Karuna Pharmaceuticals Inc.
• 31.2. Anven AlzDx Inc.
• 31.3. Merck & Co Inc.
• 31.4. Elsevier BV
• 31.5. Eurofins Discover X Corporation
• 31.6. Novus Biologicals LLC
• 31.7. Eli Lilly and Co.
• 31.8. Novatein Biosciences Inc.
• 31.9. Alomone Labs Ltd.
• 31.10. GlaxoSmithKline plc
• 31.11. SK Bioscience Co.
• 31.12. Johnson & Johnson
• 31.13. Pfizer Inc.
• 31.14. Novartis AG
• 31.15. AbbVie Inc.

32. Global Muscarinic Acetylcholine Receptor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscarinic Acetylcholine Receptor Market

34. Recent Developments In The Muscarinic Acetylcholine Receptor Market

35. Muscarinic Acetylcholine Receptor Market High Potential Countries, Segments and Strategies

• 35.1 Muscarinic Acetylcholine Receptor Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Muscarinic Acetylcholine Receptor Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Muscarinic Acetylcholine Receptor Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer